Results 1 to 10 of about 59,022 (145)

Association between alopecia areata and COVID-19: A systematic reviewCapsule Summary

open access: yesJAAD International, 2022
Background: COVID-19 may play a role in various immune-related dermatologic conditions. The relationship between COVID-19 and alopecia areata remains unclear. Objective: To review the existing literature for clinical studies and reports investigating the
Rachel E. Christensen, BS   +1 more
doaj   +2 more sources

Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis

open access: yesActa Dermato-Venereologica, 2023
The aim of this study was to compare the efficacy and safety of treatment with Janus kinase inhibitors for alopecia areata, measured by change in Severity of Alopecia Tool (SALT) score.
Farnam Barati Sedeh   +4 more
doaj   +2 more sources

Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata [PDF]

open access: yesDermatology Practical & Conceptual
Introduction: Alopecia areata (AA) is an autoimmune disorder characterized by non-scarring hair loss. Hair and nails have many commonalities related to their development and structure and both can be involved in a range of disorders.
Sara Galal   +3 more
doaj   +2 more sources

Treatment preferences by disease severity in alopecia areata: A cross-sectional survey study [PDF]

open access: yesJAAD International
Ursula Biba, BS   +6 more
doaj   +2 more sources

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment

open access: yesPrzegląd Dermatologiczny, 2023
The treatment goal in alopecia areata is induction of hair regrowth and halting the progression of the disease. Treatment decisions depend on the severity of the alopecia areata as assessed by the Severity of Alopecia Tool (SALT) or the Alopecia Areata ...
Adriana Rakowska   +8 more
doaj   +1 more source

Two Phase 3 Trials of Baricitinib for Alopecia Areata.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited.
B. King   +15 more
semanticscholar   +1 more source

Janus kinase inhibitors for alopecia areata.

open access: yesJournal of American Academy of Dermatology, 2023
Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA). Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed that; now, treatment of moderate-to-severe AA is possible.
B. King, B. Craiglow
semanticscholar   +2 more sources

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment

open access: yesPrzegląd Dermatologiczny, 2023
The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska   +8 more
doaj   +1 more source

Progress in immune pathogenesis and targeted therapy of alopecia areata

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Alopecia areata is a common clinical non-cicatricial alopecia. Alopecia totalis and generalized alopecia may occur in severe cases. The pathogenesis of alopecia areata is complex, and the treatment is faced with many difficulties.
Jiali WANG   +3 more
doaj   +1 more source

Alopecia Areata as a Proximal Risk Factor for the Development of Comorbid Depression: A Population-based Study

open access: yesActa Dermato-Venereologica, 2022
Alopecia areata and depression tend to co-occur; however, their temporal association has not been comprehensively investigated. The aim of this study was to examine the temporal association between alopecia areata and depression.
Dana Tzur Bitan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy